Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mutual Recognition's Next Evolution May Be Sharing Info On India And China Inspections

Executive Summary

Now that US FDA has approved the final EU authority, mutual recognition efforts could expand and deepen. Former FDA chief counsel Rebecca Wood discusses the future of approval standards harmonization in Pink Sheet interview.

You may also be interested in...



India’s COVID-19 Surge Forced Another Abrupt Stop Of US FDA In-Person Inspections

Agency inspectors worked in the country for about a month before the coronavirus infection surge forced another halt.

Before The Freeze: US FDA Inspection Data Pointed To Continued Foreign Facility Focus

Until the coronavirus forced it to stop, the FDA had planned to up domestic and foreign inspections in FY 2020 and FY 2021, as the longer-term trend showed domestic inspections dropping and foreign inspections rising.

US FDA Freezes Inspections And Outside Meetings. Will Review Goal Dates Stay Put?

Sponsors have been asked to switch to teleconferences with FDA staff as the agency prepares for more of its employees to work from home.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS125599

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel